US 10752626
Iso-citrate dehydrogenase (IDH) inhibitor
granted A61KA61K45/06A61P
Quick answer
US patent 10752626 (Iso-citrate dehydrogenase (IDH) inhibitor) held by SHANGHAI METON PHARMACEUTICAL CO., LTD expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SHANGHAI METON PHARMACEUTICAL CO., LTD
- Grant date
- Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00